{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T07:28:14Z","timestamp":1776929294152,"version":"3.51.2"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,9,10]],"date-time":"2015-09-10T00:00:00Z","timestamp":1441843200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s11845-015-1355-9","type":"journal-article","created":{"date-parts":[[2015,9,10]],"date-time":"2015-09-10T11:39:20Z","timestamp":1441885160000},"page":"965-967","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Listeria meningitis complicating a patient with ulcerative colitis on concomitant infliximab and hydrocortisone"],"prefix":"10.1007","volume":"185","author":[{"given":"V.","family":"Parihar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Maguire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Shahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"O\u2019Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Smyth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,10]]},"reference":[{"key":"1355_CR1","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJM199710093371502","volume":"337","author":"SR Targan","year":"1997","unstructured":"Targan SR, Hanauer SB, van Deventer SJ et al (1997) A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor for Crohn\u2019s disease. Crohn\u2019s Disease cA2 Study Group. N Engl J Med 337:1029\u20131035","journal-title":"N Engl J Med"},{"key":"1355_CR2","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1056\/NEJM199905063401804","volume":"340","author":"DH Present","year":"1999","unstructured":"Present DH, Rutgeerts P, Targan S et al (1999) Infliximab for the treatment of fistulas in patients with Crohn\u2019s disease. N Engl J Med 340:1398\u20131405","journal-title":"N Engl J Med"},{"key":"1355_CR3","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(02)08512-4","volume":"359","author":"SB Hanauer","year":"2002","unstructured":"Hanauer SB, Feagan BG, Lichtenstein GR et al (2002) ACCENT I Study Group. Maintenance infliximab for Crohn\u2019s disease: the ACCENT I randomised trial. Lancet 359:1541\u20131549","journal-title":"Lancet"},{"key":"1355_CR4","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","volume":"345","author":"J Keane","year":"2001","unstructured":"Keane J, Gershon S, Wise RP et al (2001) Tuberculosis associated with infliximab, a tumor necrosis factor\u2014neutralizing agent. N Engl J Med 345:1098\u20131104","journal-title":"N Engl J Med"},{"key":"1355_CR5","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1572-0241.2001.03612.x","volume":"96","author":"E Ricart","year":"2001","unstructured":"Ricart E, Panaccione R, Loftus EV, Tremaine WJ, Sandborn WJ (2001) Infliximab for Crohn\u2019s disease in clinical practice at the Mayo Clinic: the first 100 patients. Am J Gastroenterol 96:722\u2013729","journal-title":"Am J Gastroenterol"},{"key":"1355_CR6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.gastro.2003.10.047","volume":"126","author":"JF Colombel","year":"2004","unstructured":"Colombel JF, Loftus EV Jr, Tremaine WJ et al (2004) The safety profile of infliximab in patients with Crohn\u2019s disease: the Mayo clinic experience in 500 patients. Gastroenterology 126:19\u201331","journal-title":"Gastroenterology"},{"key":"1355_CR7","doi-asserted-by":"crossref","unstructured":"Ljung T, Karlen P, Schmidt D et al (2004) Infliximab in inflammatory bowel disease: Clinical outcome in a population based cohort from Stockholm County. Gut 53:849\u2013853","DOI":"10.1136\/gut.2003.018515"},{"key":"1355_CR8","first-page":"1530","volume-title":"Textbook of gastroenterology","author":"HB Greenberg","year":"1999","unstructured":"Greenberg HB, Matsui SM, Holodniy M (1999) Small intestine: Infections with common bacterial and viral pathogens. In: Yamada T, Alpers DH, Laine L, Owyang C, Powell DW (eds) Textbook of gastroenterology, 3rd edn. Lippincott Williams & Wilkins, Philadelphia, pp 1530\u20131560","edition":"3"},{"key":"1355_CR9","first-page":"1864","volume-title":"Sleisenger and Fordtran\u2019s Gastrointestinal and Liver Disease","author":"DH Hamer","year":"2002","unstructured":"Hamer DH, Gorbach SL (2002) Infectious diarrhea and bacterial food poisoning. In: Feldman M, Friedman LS, Sleisenger MH (eds) Sleisenger and Fordtran\u2019s Gastrointestinal and Liver Disease, 7th edn. WB Saunders Company, Philadelphia, pp 1864\u20131913","edition":"7"},{"key":"1355_CR10","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/rheumatology\/41.8.951","volume":"41","author":"TL Tai","year":"2002","unstructured":"Tai TL, O\u2019Rourke KP, McWeeney M, Burke CM, Sheehan K, Barry M (2002) Pneumocystis carinii pneumonia following a second infusion of infliximab. Rheumatology (Oxford) 41:951\u2013952","journal-title":"Rheumatology (Oxford)"},{"key":"1355_CR11","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJM200104053441415","volume":"344","author":"A Warris","year":"2001","unstructured":"Warris A, Bjorneklett A, Gaustad P (2001) Invasive pulmonary aspergillosis associated with infliximab therapy. N Engl J Med 344:1099\u20131100","journal-title":"N Engl J Med"},{"key":"1355_CR12","first-page":"1100","volume":"344","author":"GF Keenan","year":"2001","unstructured":"Keenan GF, Schaible TF, Boscia JA (2001) Invasive pulmonary aspergillosis associated with infliximab therapy (reply). N Engl J Med 344:1100","journal-title":"N Engl J Med"},{"key":"1355_CR13","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1002\/art.10583","volume":"46","author":"JH Lee","year":"2002","unstructured":"Lee JH, Slifman NR, Gershon SK et al (2002) Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor antagonists infliximab and etanercept. Arthritis Rheum 46:2565\u20132570","journal-title":"Arthritis Rheum"},{"key":"1355_CR14","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0002-9343(01)00945-7","volume":"112","author":"M Nakelchik","year":"2002","unstructured":"Nakelchik M, Mangino JE (2002) Reactivation of histoplasmosis after treatment with infliximab. Am J Med 112:78","journal-title":"Am J Med"},{"key":"1355_CR15","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1111\/j.1572-0241.2003.08757.x","volume":"98","author":"A Diamanti","year":"2003","unstructured":"Diamanti A, Papadatou B, Knafelz D, Gambarara M, Ferretti F, Castro M (2003) Complications of infliximab therapy in children and adolescents affected by Crohn\u2019s disease. Am J Gastroenterol 98:2812\u20132813","journal-title":"Am J Gastroenterol"},{"key":"1355_CR16","unstructured":"Remicade (infliximab) for IV injection. Package Insert. Pennsylvania: Centocor Inc, 2003. http:\/\/www.remicade.com\/pdf\/PPI.pdf"},{"key":"1355_CR17","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1572-0241.2000.01872.x","volume":"95","author":"J Morelli","year":"2000","unstructured":"Morelli J, Wilson FA (2000) Does administration of infliximab increase susceptibility to listeriosis? Am J Gastroenterol 95:841\u2013842","journal-title":"Am J Gastroenterol"},{"key":"1355_CR18","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/art.10758","volume":"48","author":"NR Slifman","year":"2003","unstructured":"Slifman NR, Gershon SK, Lee JH, Edwards ET, Braun MM (2003) Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor\u2014neutralizing agents. Arthritis Rheum 48:319\u2013324","journal-title":"Arthritis Rheum"},{"key":"1355_CR19","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1053\/j.gastro.2008.01.012","volume":"134","author":"M Toruner","year":"2008","unstructured":"Toruner M, Loftus E, Harmesan W et al (2008) Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology 134:929\u2013936","journal-title":"Gastroenterology"},{"key":"1355_CR20","doi-asserted-by":"crossref","unstructured":"Willson KJ, Jacob A, Shetti MP, Bhatia R, Yee K, Osler W (2012) Listeria monocytogenes infection in Crohn\u2019s disease treated with adalimumab Med J Aust 197(8):466\u2013467","DOI":"10.5694\/mja11.10521"},{"key":"1355_CR21","unstructured":"FDA Drug Safety Communication: Drug labels for the tumor necrosis factor-\u03b1 (TNF\u03b1) blockers now include warnings about infection with Legionella and Listeria bacteria"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-015-1355-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11845-015-1355-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-015-1355-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-015-1355-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T19:15:00Z","timestamp":1559416500000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11845-015-1355-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,10]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["1355"],"URL":"https:\/\/doi.org\/10.1007\/s11845-015-1355-9","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,10]]}}}